Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer (Q90360938)
Jump to navigation
Jump to search
scientific article published on 20 July 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer |
scientific article published on 20 July 2018 |
Statements
Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer (English)
Karina Kulangara
Nancy Zhang
Ellie Corigliano
Lindsay Guerrero
Stephanie Waldroup
Dipeshkumar Jaiswal
Malinka Jansson Ms
Supriya Shah
Debra Hanks
Jiangdian Wang
Jared Lunceford
Mary J Savage
Jonathan Juco
Kenneth Emancipator